Epidemiological aspects and disease association of childhood vitiligo
Keywords:
Vitiligo, thyroid abnormality, childrenAbstract
Objective To determine, for the first time in Iran, different epidemiological aspects and association of vitiligo with diseases between children and adults.Methods This was a cross-sectional study with 324 participants, divided into 3 groups, each consisting of 108 of cases. The first group consisted of sex matched adults with vitiligo, second group were children between 2 and 18 years old with vitiligo (case group) and the third group were children with other skin disorders being matched for age and sex. Laboratory tests such as FBS, thyroid function test, CBC/Differentials and anti TPO antibody obtained from the participants and the type of the vitiligo was recorded.Results Our findings showed that thyroid abnormalities were seen in 4.5% of children of the case group. FBS was higher in only one child with vitiligo. Family history of vitiligo was significantly different between children with vitiligo and those with other skin disorders (p=0.001).Conclusion In our research, most of the children with vitiligo had positive anti-TPO antibody, confirming the importance of anti –TPO screening test in vitiligo patients.References
Halder RM, Grimes PE, Cowan CA et al. Childhood vitiligo. J Am Acad Dermatol. 1987;16:948-54.
Kovacs SO. Vitiligo. J Am Acad Dermatol. 1998;38:647-66.
Alkhateeb A, Fain PR, Thody A et al. Epidemiology of vitiligo and associated autoimmune disease in Caucasian probands and their families. Pigment Cell Res. 2003;16:208-14.
Huggins RH, Schwartz RA, Krysica J. Vitiligo. Acta Dermatoven APA. 2005;14:137-45.
Liu JB, Li M, Yang S et al. Clinical profile of vitiligo in China:an analysis of 3742 patients. Clin Exp Dermatol 2005;30:327-31.
Lu T, Gao T, Wang A et al. Vitiligo prevalence study in Shaanxi province, China. Int J Dermatol. 2007;46:47-51.
Handa S, Kaurt I. Vitiligo: clinical finding in 1436 patients. J Dermatol. 1999;26:653-7.
Cho S, Kang HC, Hahm JH. Charactrisic of vitiligo in Korean children. Pediatr Dermatol. 2000;17:189-93.
Kakourou T, Kanaka-Gantenbein C, Papadopoulou A et al. Increased prevalence of chronic autoimmue (Hashimoto’s) thyroidtis in children and adolescents with vitiligo. J Am Acad Dermatol. 2005;53:220-3.
Kurtev A, Douramishev AL. Thyroid function and autoimmunity in children and adolescents with vitiligo. J Eur Acad Dermatol Venereol. 2004;18:99-117.
Sehgal VN, Srivastava G. Vitiligo: Autoimmunity and immune response. Int J Dermatol. 2006;45:583-90
Gopal KV, Ramarao GR, Kummar YH et al. Vitiligo: a part of a systemic autoimmune process. Indian J Dermatol Venerol Leprol. 2007;73:162-5.
Hu Z, liu J.B Ma SS et al. Profile of childhood vitiligo in china: an analysis of 541 patients. Ped Deramtol. 2006;23:114-6.
Almutairi N, Sharma AK, Alsheltawy M et al. Childhood vitiligo: a prospective hospital based study. Aust J Dermatol. 2005;46:150-3.
Farjzadeh S, Daraei Z, Esfandiarpour I et al. The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of segmentalvitiligo: a randomized placebo controlled study. Pediatr Dermatol. 2009;26:286-91.
Lacovelli P, Sinagra JLM, Vidolin AP et al. Prevalence of thyroiditis and of other auto immune disease children with vitiligo. Dermatology. 2005;210:26-39.
Esfandiarpour I, Farajzadeh S. Clinical characteristics of late onset vitiligo in an Iranian population. Dermatologica Sinica. 2012;30:43-6.
Dogra S, Parsad D, Handa S et al. Late onset vitiligo: a study of 182 patients. Int J Dermatol. 2005;44:193-6.
Kovacs SO. Vitiligo. J Am Acad Dermatol. 1998;38:647-66.
Daneshpazhooh M, Mostofizadeh M, Behjati J et al. Anti-thyroid peroxidase antibody and vitiligo: a controlled set. BMC Dermatol. 2006;6:3.
